Effect of Optimized Immunosuppression (Including Rituximab) on Anti-Donor Alloresponses in Patients With Chronically Rejecting Renal Allografts. (2020)

First Author: Shiu KY
Attributed to:  MRC Centre for Transplantation funded by MRC


No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2020.00079

PubMed Identifier: 32117242

Publication URI: http://europepmc.org/abstract/MED/32117242

Type: Journal Article/Review

Volume: 11

Parent Publication: Frontiers in immunology

ISSN: 1664-3224